Remove Behavioural Health Remove Business Development Remove Marketing Remove Research
article thumbnail

Changing Faces: pharma supplier, DTx, and non-profit hires from November 2022

pharmaphorum

Digital therapeutics company Cognoa, which focuses on paediatric behavioural health, announced the appointment of Dr Sharief Taraman as its new CEO. Drawing on 25 years in clinical research, White will oversee Saama’s project delivery teams. We’ve rounded up some highlights below. Digital therapeutics hires.

article thumbnail

Partnering to advance digital therapeutics offerings

pharmaphorum

Aaron Gani, founder and CEO of BehaVR, and Krys Zaluski, director of business development, digital health at Sumitomo Dainippon Pharma, discuss their groundbreaking partnership to develop and commercialise digital therapeutics (DTx) products. . Gani started BehaVR in 2016 to create DTx for mental and behavioural health.

article thumbnail

What we’re expecting in 2021, and beyond…

pharmaphorum

There is an opportunity to address this at scale with digital tools and techniques, and expand support into just about any therapeutic area through the holistic integration of mental and behavioural health solutions that improve patient care. Consolidation of digital health platforms.